Tosylate salt of a 5-pyrazolyl-2-pyridone derivative, useful in the treatment of COPD

Details for Australian Patent Application No. 2010215269 (hide)

Owner AstraZeneca AB

Inventors Alcaraz, Marie-Lyne; Briggner, LarsErik; Klingstedt, Per Tomas; Lonn, Hans Roland; Nicklasson, Helena; Nixon, Robert Anthony; Watts, Andrew James; Zuban, Robert

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2010215269

PCT Pub. Number WO2010/094964

Priority 61/154,099 20.02.09 US

Filing date 18 February 2010

Wipo publication date 26 August 2010

International Classifications

C07D 401/14 (2006.01) Heterocyclic compounds containing two or more hetero rings

A61K 31/4439 (2006.01)

A61P 11/00 (2006.01) Drugs for disorders of the respiratory system

Event Publications

25 August 2011 PCT application entered the National Phase

  PCT publication WO2010/094964 Priority application(s): WO2010/094964

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010215273-Surface treatment process for implantable medical device

2010215268-Refill liquid container